Trial NCT01531803

View at ClinicalTrials.gov 
Org. Study IDs: KB058

Last trial update was posted on 2023-11-15

MeSH Interventions

Pharmaceutical Solutions

MeSH Conditions

Hypovolemia

Other Conditions


Stopping Reasons

Per FDA CBER letter dated July 15, 2015, Kedrion SpA was released from the PMC to perform the study with Kedbumin 25% in pediatric patients.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID